Guangdong Lifestrong Pharmacy Co., Ltd. (301111.SZ)
CNY 17.22
(1.89%)
CNY 17.22
(1.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.79 Million | 69.87 Million | 71.62 Million | 90.9 Million | 48.7 Million | 41.39 Million |
| Net Income | 32.53 Million | 33.41 Million | 57.18 Million | 62.52 Million | 66.63 Million | 63.6 Million |
| Depreciation & Amortization | 13.3 Million | 12.21 Million | 14.85 Million | 11.39 Million | 8.79 Million | 8.05 Million |
| Deferred income taxes | 12.92 Thousand | -8.95 Million | -1.48 Million | 3.69 Million | 469.6 Thousand | -1.12 Million |
| Stock-based compensation | - | 557.58 Thousand | 557.58 Thousand | - | 5.09 Million | - |
| Change in working capital | -52.87 Million | 31.51 Million | -2.48 Million | 17.09 Million | -34.81 Million | -32.15 Million |
| Other non-cash items | -5.76 Million | 1.12 Million | 2.99 Million | -102.6 Thousand | 2.52 Million | 1.9 Million |
| Investing Cash Flow | -19.3 Million | -304.66 Million | -76.85 Million | -70.28 Million | -74.21 Million | 5.07 Million |
| Investments in PPE | -38.61 Million | -5.54 Million | -3.09 Million | -46.1 Million | -12.82 Million | -1.35 Million |
| Acquisitions | - | 150 Thousand | 5332.50 | 46.54 Million | 12.93 Million | 1.38 Million |
| Investment purchases | -297 Million | -959 Million | -169.03 Million | -140 Million | -142 Million | -132 Million |
| Sales/Maturities of investments | 316.3 Million | 659.72 Million | 95.25 Million | 115.37 Million | 80.5 Million | 138.39 Million |
| Other Investing Activities | 0.26 | 0.98 | 0.91 | -46.1 Million | -12.82 Million | -1.35 Million |
| Financing Cash Flow | -17.08 Million | -35.75 Million | 379.05 Million | -14.64 Million | -30 Million | -47.46 Million |
| Debt repayment | -1.08 Million | -955.29 Thousand | -836.17 Thousand | - | - | -46.7 Million |
| Dividends payments | -16 Million | -25.6 Million | - | -10.8 Million | -30 Million | -764.64 Thousand |
| Common Stock Repurchased | - | 10.15 Million | - | - | - | - |
| Common Stock Issuance | - | -9.2 Million | -6.82 Million | - | - | - |
| Other Financing Activities | -1.08 Million | -10.15 Million | 386.71 Million | -3.84 Million | - | -764.64 Thousand |
| Accounts receivables | -3.19 Million | 24.37 Million | -14.05 Million | -1.66 Million | -15.64 Million | -33.96 Million |
| Accounts payables | -34.34 Million | 35.08 Million | 10.02 Million | 10.97 Million | -17.16 Million | -4.43 Million |
| Inventory | -15.34 Million | -18.98 Million | 3.03 Million | 4.08 Million | -2.47 Million | 7.36 Million |
| Other working capital | -37.52 Million | -8.95 Million | -1.48 Million | 3.69 Million | 469.66 Thousand | -39.51 Million |
| Cash at beginning of period | 147.73 Million | 418.28 Million | 44.45 Million | 38.47 Million | 93.98 Million | 94.98 Million |
| Cash at end of period | 98.54 Million | 147.73 Million | 418.28 Million | 44.45 Million | 38.47 Million | 93.98 Million |
| Capital Expenditure | -38.61 Million | -5.54 Million | -3.09 Million | -46.1 Million | -12.82 Million | -1.35 Million |
| Effect of forex changes on cash | - | - | 0.57 | -0.03 | - | 1.53 |
| Net cash flow / Change in cash | -49.18 Million | -270.54 Million | 373.82 Million | 5.98 Million | -55.51 Million | -996.07 Thousand |
| Free Cash Flow | -51.41 Million | 64.33 Million | 68.53 Million | 44.8 Million | 35.87 Million | 40.04 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1 Million | 3.36 Million | 11.73 Million | 32.53 Million | 3 Million | 5.68 Million |
| Depreciation & Amortization | - | 3.16 Million | 3.16 Million | 13.3 Million | 13.3 Million | -5.79 Million |
| Deferred income taxes | - | - | - | 12.92 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -52.87 Million | -18.53 Million | -940.1 Thousand |
| Other non-cash items | 6.75 Million | -12.67 Million | -10.8 Million | -5.76 Million | 6.87 Million | -215.46 Thousand |
| Investing Cash Flow | -19.75 Million | 36.99 Million | -9.08 Million | -19.3 Million | 760.22 Thousand | -7.91 Million |
| Investments in PPE | -15.15 Million | -9 Million | -3.93 Million | -38.61 Million | -5.96 Million | -5.67 Million |
| Acquisitions | -5.1 Million | - | - | - | - | 2.23 Million |
| Investment purchases | -2.5 Million | -60.99 Million | -50.15 Million | -297 Million | -75 Million | -120 Million |
| Sales/Maturities of investments | 3 Million | 107 Million | 45 Million | 316.3 Million | 81.72 Million | 117.76 Million |
| Other Investing Activities | - | - | -4.14 Million | 0.26 | 0.58 | -2.23 Million |
| Financing Cash Flow | 614.92 Thousand | -13.94 Million | -284.8 Thousand | -17.08 Million | -230.19 Thousand | -354.51 Thousand |
| Debt repayment | - | - | - | -1.08 Million | - | - |
| Dividends payments | -16 Million | -16 Million | - | -16 Million | -16 Million | -16 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -15.38 Million | 2.72 Million | -284.8 Thousand | -1.08 Million | -235.4 Thousand | 15.64 Million |
| Accounts receivables | - | - | - | -3.19 Million | -3.19 Million | -4.94 Million |
| Accounts payables | - | - | - | -34.34 Million | - | - |
| Inventory | - | - | - | -15.34 Million | -15.34 Million | 4 Million |
| Other working capital | - | - | - | -37.52 Million | - | - |
| Cash at beginning of period | 133.8 Million | 122.94 Million | 131.1 Million | 147.73 Million | 93.36 Million | 105.66 Million |
| Cash at end of period | 120.68 Million | 133.8 Million | 122.94 Million | 98.54 Million | 98.54 Million | 93.36 Million |
| Capital Expenditure | -15.15 Million | -9 Million | -3.93 Million | -38.61 Million | -5.96 Million | -5.67 Million |
| Effect of forex changes on cash | - | - | - | - | - | -2.76 Million |
| Net cash flow / Change in cash | -13.11 Million | 10.85 Million | -8.16 Million | -49.18 Million | 5.18 Million | -12.29 Million |
| Free Cash Flow | -9.4 Million | -21.48 Million | -3 Million | -51.41 Million | -1.31 Million | -6.93 Million |
LKFN
HVO
8013
APEX
INVERCAP
3628